M. Kraus & Co’s Eli Lilly LLY Stock Holding History

M. Kraus & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$852K	Hold	926	–	–	0.25%	42
2025 Q4	$995K	Sell	926 -34	-4%	-$32.5K	0.28%	44
2025 Q3	$732K	Hold	960	–	–	0.2%	49
2025 Q2	$748K	Sell	960 -25	-3%	-$19.4K	0.22%	49
2025 Q1	$814K	Hold	985	–	–	0.25%	45
2024 Q4	$760K	Hold	985	–	–	0.23%	46
2024 Q3	$873K	Hold	985	–	–	0.26%	42
2024 Q2	$892K	Sell	985 -29	-3%	-$23.2K	0.27%	41
2024 Q1	$789K	Sell	1,014 -15	-1%	-$10.7K	0.24%	42
2023 Q4	$600K	Sell	1,029 -59	-5%	-$34.4K	0.2%	46
2023 Q3	$584K	Hold	1,088	–	–	0.21%	46
2023 Q2	$510K	Sell	1,088 -5	-0.5%	-$2.1K	0.17%	48
2023 Q1	$375K	Sell	1,093 -4	-0.4%	-$1.35K	0.13%	58
2022 Q4	$401K	Buy	1,097 +406	+59%	+$144K	0.15%	55
2022 Q3	$223K	Buy	+691	New	+$219K	0.09%	65

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

M. Kraus & Co's LLY Position: Q1 2026 in Review

M. Kraus & Co held its Eli Lilly (LLY) position steady in Q1 2026 at 926 shares worth $852K. The position accounts for 0.25% of the portfolio, ranked #42.

M. Kraus & Co first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $995K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

M. Kraus & Co held 926 shares of Eli Lilly worth $852K as of Q1 2026.
M. Kraus & Co left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.25% of M. Kraus & Co's portfolio in Q1 2026, its #42 holding.
M. Kraus & Co first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
M. Kraus & Co's Eli Lilly position peaked at $995K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on M. Kraus & Co's 13F filing for Q1 2026, filed 14 Apr 2026.